TriSalus Life Sciences (TLSIW) Change in Intangibles (2022 - 2023)
TriSalus Life Sciences (TLSIW) reported Change in Intangibles of $328000.0 for Q4 2023, up 382.35% on a YoY basis from $68000.0 in Q4 2022, and up 135.97% quarter-over-quarter from $139000.0 in Q3 2023.
TriSalus Life Sciences (TLSIW) Change in Intangibles (2022 - 2023) Analysis & Trends
TriSalus Life Sciences has reported Change in Intangibles for 2 years, with the latest figure at $328000.0 in Q4 2023.
- For the quarter ending Q4 2023, Change in Intangibles rose 382.35% year-over-year to $328000.0; the trailing twelve-month figure through Jun 2024 stood at $467000.0 (changed N/A YoY), and the FY2023 full-year result was $533000.0, up 306.87% from the prior year.
- Change in Intangibles for Q4 2023 stood at $328000.0, up from $139000.0 in the prior quarter.
- The five-year high for Change in Intangibles was $328000.0 in Q4 2023, with the low at -$1000.0 in Q2 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | - |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | - |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | - |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | - |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -31.61 Mn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | - |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | - |
| 10 | TriSalus Life Sciences | - | - | 7.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 328,000.00 |
| Dec 31, 2023 | 328,000.00 |
| Sep 30, 2023 | 139,000.00 |
| Sep 30, 2023 | 139,000.00 |
| Jun 30, 2023 | -1,000.00 |
| Jun 30, 2023 | -1,000.00 |
| Mar 31, 2023 | 67,000.00 |
| Mar 31, 2023 | 67,000.00 |
| Dec 31, 2022 | 68,000.00 |
| Dec 31, 2022 | 68,000.00 |